In this study, we found that TFPI2 is downregulated in HCC tissues and cells, and its downregulation may be caused by DDX17-mediated inactivation of the TFPI2 promoter, but the mechanism still needs to be fully elucidated. This evidence concerns the gene DDX17 and hepatocellular carcinoma.